PUBLISHER: Grand View Research | PRODUCT CODE: 2151510
PUBLISHER: Grand View Research | PRODUCT CODE: 2151510
The global immunology market size was valued at USD 113.2 billion in 2025, and is projected to grow from USD 124.9 billion in 2026 to USD 299.3 billion in 2035, at a CAGR of 10.2% from 2026 to 2035. North America dominated the market, accounting for a revenue share of 50.0% in 2025. The global market encompasses therapeutics and biopharmaceutical products used to prevent, manage, and treat immune system-related disorders, including autoimmune diseases, inflammatory conditions, immunodeficiencies, and transplant rejection.
The pace of innovation in the immunology industry has accelerated significantly, driven by advancements in precision medicine, biologics, and targeted small-molecule therapies. A deeper understanding of immune system pathways and disease mechanisms has supported the development of Janus kinase (JAK) inhibitors, interleukin (IL) inhibitors, and other targeted immunomodulatory agents. Advancements in biomarkers, companion diagnostics, and molecular profiling are further enabling more precise patient stratification and treatment selection.
The growth is also driven by the increasing prevalence of autoimmune and chronic inflammatory disorders, the rising adoption of biologic therapies, and growing healthcare expenditure. Pharmaceutical and biotechnology companies are making substantial investments in clinical research, biosimilar development, and next-generation immunomodulatory therapies to expand treatment options and improve patient access. In addition, supportive regulatory pathways for innovative biologics, expanding specialty care infrastructure, and increasing availability of advanced treatment options are facilitating the commercialization and adoption of immunology therapeutics across major healthcare markets.
The market is expected to present significant growth opportunities due to continued investment in immunology research, advancements in biologics manufacturing, and the development of next-generation therapeutic modalities. Emerging approaches, including cell-based immunotherapies, next-generation monoclonal antibodies, bispecific antibodies, and artificial intelligence-enabled drug discovery, are expected to influence the future treatment landscape. However, high treatment costs, pricing pressures, biosimilar competition, and reimbursement challenges may affect market dynamics. Nevertheless, the growing demand for targeted and personalized therapies is expected to support the long-term expansion of the market.
Global Immunology Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2035. For this study, Grand View Research has segmented the global immunology market report based on drug class, disease indication, distribution channel, and region:
Monoclonal Antibodies
Fusion Proteins
Immunosuppressants
Polyclonal Antibodies
Others
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Atopic Dermatitis
Inflammatory Bowel Disease
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
Europe
Asia Pacific
Central & South America
Middle East and Africa (MEA)